Search Results - Eric A. Collisson

Refine Results
  1. 1
    Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma

    Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma by Avital Klein-Brill, Shlomit Amar-Farkash, Gabriella Lawrence, Eric A. Collisson, Dvir Aran

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer

    Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer by Man-Tzu Wang, Nicole Fer, Jacqueline Galeas, Eric A. Collisson, Sung Eun Kim, Jeremy Sharib, Frank McCormick

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Single-molecule superresolution imaging allows quantitative analysis of RAF multimer formation and signaling

    Single-molecule superresolution imaging allows quantitative analysis of RAF multimer formation and signaling by Xiaolin Nan, Eric A. Collisson, Sophia Lewis, Jing Huang, Tanja Tamgüney, Jan Liphardt, Frank McCormick, Joe W. Gray, Steven Chu

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

    Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway by Xiaolin Nan, Tanja Tamgüney, Eric A. Collisson, Li-Jung Lin, Cameron Pitt, Jacqueline Galeas, Sophia Lewis, Joe W. Gray, Frank McCormick, Steven Chu

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation

    Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation by Nilotpal Roy, Shivani Malik, Karina E. Villanueva, Atsushi Urano, Xinyuan Lu, Guido von Figura, E. Scott Seeley, David W. Dawson, Eric A. Collisson, Matthias Hebrok

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome

    Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome by Eric A. Collisson, Hamid Nourmand, Mark H. Fraiman, Christopher B. Cooper, Paul E. Bellamy, Douglas G. Farmer, John M. Vierling, Rafik M. Ghobrial, Ronald W. Busuttil

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma

    Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma by Robert J. Torphy, Zhen Wang, Aisha True‐Yasaki, Keith E. Volmar, Naim U. Rashid, Benjamin M. Yeh, Julia S. Johansen, Michael A. Hollingsworth, Jen Jen Yeh, Eric A. Collisson

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    <i>MET</i> Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma

    <i>MET</i> Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma by Xinyuan Lu, Nir Peled, John J. Greer, Wei Wu, Peter S. Choi, Alice H. Berger, Sergio Wong, Kuang‐Yu Jen, Youngho Seo, Byron Hann, Angela N. Brooks, Matthew Meyerson, Eric A. Collisson

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer

    Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer by Luping Lin, Saurabh Asthana, Elton Chan, Sourav Bandyopadhyay, Maria M. Martins, Victor Olivas, Jenny Yan, Luu Pham, Mingxue Michelle Wang, Gideon Bollag, David B. Solit, Eric A. Collisson, Charles M. Rudin, Barry S. Taylor, Trever G. Bivona

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls

    Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls by Robin Kate Kelley, Mark Jesus M. Magbanua, Timothy Butler, Eric A. Collisson, Jimmy J. Hwang, Nikoletta Sidiropoulos, Kimberley Evason, Ryan M. McWhirter, Bilal Hameed, Elizabeth M. Wayne, Francis Y. Yao, Alan P. Venook, John W. Park

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma

    A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma by Eric A. Collisson, Christy L. Trejo, Jillian M. Silva, Shenda Gu, James E. Korkola, Laura M. Heiser, Roch‐Philippe Charles, Brian Rabinovich, Byron Hann, David Dankort, Paul T. Spellman, Wayne A. Phillips, Joe W. Gray, Martin McMahon

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    A DNA hypermethylation module for the stem/progenitor cell signature of cancer

    A DNA hypermethylation module for the stem/progenitor cell signature of cancer by Hariharan Easwaran, Sarah E. Johnstone, Leander Van Neste, Joyce E. Ohm, Tim Mosbruger, Qiuju Wang, Martin J. Aryee, Patrick F. Joyce, Nita Ahuja, Dan Weisenberger, Eric A. Collisson, Jingchun Zhu, Srinivasan Yegnasubramanian, William Matsui, Stephen B. Baylin

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Stromal cues regulate the pancreatic cancer epigenome and metabolome

    Stromal cues regulate the pancreatic cancer epigenome and metabolome by Mara H. Sherman, Ruth T. Yu, Tiffany Tseng, Cristovão M. Sousa, Sihao Liu, Morgan Truitt, Nanhai He, Ning Ding, Christopher Liddle, Annette R. Atkins, Mathias Leblanc, Eric A. Collisson, John M. Asara, Alec C. Kimmelman, Michael Downes, Ronald M. Evans

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

    Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA by Richard B. Lanman, Stefanie Mortimer, Oliver A. Zill, Dragan Sebisanovic, René López, Sibel Blau, Eric A. Collisson, Stephen G. Divers, Dave S.�B. Hoon, Scott Kopetz, Jeeyun Lee, Petros Nikolinakos, Arthur M. Baca, Bahram G. Kermani, Helmy Eltoukhy, AmirAli Talasaz

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients

    A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients by Rafik M. Ghobrial, Randy Steadman, Jeffery Gornbein, Charles Lassman, Curtis Holt, Pauline Chen, Douglas G. Farmer, Hasan Yersiz, Natale Danino, Eric A. Collisson, Angeles Baquarizo, Steve Han, Sammy Saab, Leonard I. Goldstein, John A. Donovan, Karl Esrason, Ronald W. Busuttil

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma

    Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma by Jeffrey P. North, Justin Golovato, Charles Vaske, Zack Sanborn, Andrew Nguyen, Wei Wu, Benjamin Goode, Meredith Stevers, Kevin P. McMullen, Bethany E. Perez White, Eric A. Collisson, Michele M. Bloomer, David A. Solomon, Stephen C. Benz, Raymond J. Cho

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A colorectal cancer classification system that associates cellular phenotype and responses to therapy

    A colorectal cancer classification system that associates cellular phenotype and responses to therapy by Anguraj Sadanandam, Costas A. Lyssiotis, Krisztián Homicskó, Eric A. Collisson, William J. Gibb, Stephan Wullschleger, Liliane C Gonzalez Ostos, William A Lannon, Carsten Grötzinger, Maguy Del Rio, Benoît Lhermitte, Adam B. Olshen, Bertram Wiedenmann, Lewis C. Cantley, Joe W. Gray, Douglas Hanahan

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas

    Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas by Oliver A. Zill, Claire Greene, Dragan Sebisanovic, Lai Mun Siew, Jim Leng, Mary Vu, Andrew Hendifar, Zhen Wang, Chloé E. Atreya, Robin Kate Kelley, Katherine Van Loon, Andrew H. Ko, Margaret A. Tempero, Trever G. Bivona, Pamela N. Münster, AmirAli Talasaz, Eric A. Collisson

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

    Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy by Eric A. Collisson, Anguraj Sadanandam, Peter Olson, William J. Gibb, Morgan Truitt, Shenda Gu, J. Cooc, Jennifer Weinkle, Grace Kim, Lakshmi R. Jakkula, Heidi S. Feiler, Andrew H. Ko, Adam B. Olshen, Kathleen L Danenberg, Margaret A. Tempero, Paul T. Spellman, Douglas Hanahan, Joe W. Gray

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

    A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma by Andrew H. Ko, Tanios Bekaii‐Saab, Jessica Van Ziffle, Olga K. Mirzoeva, Nancy M. Joseph, AmirAli Talasaz, Peter Kühn, Margaret A. Tempero, Eric A. Collisson, Robin Kate Kelley, Alan P. Venook, Elizabeth Dito, Anna Ong, Sharvina Ziyeh, Ryan Courtin, Regina Linetskaya, Sanaa Tahiri, W. Michael Korn

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: